Join us at RheumNow Live this March! Dr. Janet Pope ( @janetbirdnope) will be back to discuss decisive therapeutics in RA. https://t.co/1aUe1mk4La https://t.co/R1xRMDK6MK

Herpes Zoster with JAK Inhibitors A recent review a higher HZ risk with JAKi therapy shows the HZ-risk in RA and UC to be higher than PsA when treated with usual doses of TOFA, especially those given higher TOFA doses or concomitant glucocorticoids. https://t.co/rlYXJWONyS https://t.co/nwqbbp6Ci3

Is JAKi therapy safe in RA-ILD pts? Italian retrospective study (2018-June 2022) w/ 43 RA pts & HRCT proven ILD (med age 69yrs) & Rx w/ JAKi. After 19 mos F/U, the FVC was stable in 79%, improved in 11%, & worse in 11%. DLCO & HRCT trend was similar. https://t.co/T0rP96FM0Z https://t.co/W8NFtfevQg

Rretroperitoneal fibrosis Tx is fraut-steroids, tamoxifen, MMF, B cell therapy? OL trial in 8 RPF pts used steroids & mTOR inhibitor sirolimus (2mg/d x 3d; 1mg/d); 12 & 48wks - decr in fibrous tissue 50%, ESR 70%, IgG4 50% w/ normalized renal funct. https://t.co/LbptMLCiJO

Can something as simple as a cup of coffee with milk have an anti-inflammatory effect in humans? Apparently so, according to a new study. A combination of proteins and antioxidants doubles the anti-inflammatory properties. https://t.co/vuZwsrojwH https://t.co/NFNqHOKuOz

FDA has approved the 1st BTK (Bruton’s tyrosine kinase) inhibitor (Jaypirca™ or pirtobrutinib) for adults with refractory mantle cell lymphoma. BTK inhibitors are also being developed for use in MS, RA, SLE, pemphigus & more https://t.co/599tK21H1Z https://t.co/KSqMMDWmfd

US Postage, circa 1949 "The Doctor" from a painting done by Sir Luke Fildes, “The Doctor” 1891. Portrays the values of the ideal physician and the inadequacies of the medical profession. Child in a 'crisis' (forefront) and ' dawn' light represents hope. https://t.co/OaECk6MlMZ

Jan 2023 Medscape Physician Burnout Report: lists Rheum @ #10 (down from #2) 1 Emergency med 65% 2 Int med 60% 3 Peds 59% 4 OB & ID 58% 5 Family med 57% 6 Neuro, Anesth 55% 7 Pulm, XRay 54% 8 Onc, GI 52% 9 Surgery, Endo 51% 10 Rheum 50% https://t.co/n66oi1Ah73 https://t.co/qTF4t2NTca

German survey on telemedicine (TM) in 438 MSK patients - 63% response; showed reasons against interest in TM included: - Not yet diagnosed - No prior TM - Bad health status - Rural living - Not owning electronic device - Aged 60-80 yrs https://t.co/niO00pCuTY https://t.co/07KFNWMs1N